Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Shutterstock/Triff

College graduates at higher risk of cancerous brain tumours, researchers find

“It was a surprising result which is difficult to explain,” the lead author of the study said.

PEOPLE WITH AT least three years of higher education are at greater risk for cancerous brain tumours than those with no more than nine years of schooling, perplexed researchers have found.

“There is a 19% increased risk that university-educated men could be diagnosed with glioma,” said Amal Khanolkar, a scientist at the Institute of Child Health in London and lead author of a study in the Journal of Epidemiology and Community.

For women, he said, the risk rose by 23%.

“It was a surprising result which is difficult to explain,” Khanolkar told AFP.

Concretely, the increase in risk is minimal because such brain tumours are rare.

At the lowest level of education, the chances of glioma were reported at five in 3,000. At the other end of the educational spectrum, the odds increased to six in 3,000.

But the question remained as to whether the gap – no matter how small – was real and, if so, what caused it.

Earlier research exploring a possible link between education or social level, on the one hand, and the frequency of brain tumours, on the other, had been inconclusive.

To “put to rest” these conflicting findings, Khanolkar and colleagues at the Karolinska Institute medical university in Stockholm used a new approach.

Rather than comparing a small number of brain tumour patients with healthy individuals, they sifted through the health records of 4.3 million adults tracked by the Swedish public health system from 1993 to 2011.

The researchers distinguished between three kinds of brain tumours – two of them non-cancerous – with different causes.

The strong link between education level and tumour incidence held for all three types, but was strongest for deadly gliomas.

Interestingly, an even higher risk gap was found between low-income manual labourers and high-income men and women who did not work with their hands.

Why?

Gliomas are malignant brain tumours which grow rapidly and cause severe symptoms, including migraines, nausea and memory loss.

The survival rate is very low.

The study did not seek to explain the link between higher education and tumours, nor did it consider the potential impact of environmental and lifestyle factors, such as smoking or alcohol consumption.

The most common explanation for risk levels that rise with years spent in the classroom is that people with a higher education or income “have a better awareness of symptoms,” Khanolkar said.

This would mean they are more likely to seek help and receive a correct diagnosis.

But while this may be true in a country with a health system that clearly favours the well-to-do, the argument is far less convincing in the Swedish context, the researchers said.

“Sweden has a universal, tax-based health care system,” said Khanolkar. Everybody has roughly the same access to treatment.

Moreover, he added, gliomas form very rapidly – often within 48 hours – and are excruciatingly painful.

“The symptoms are not avoidable – you can’t sit at home and not seek care,” he said.

To further their probe, the team will canvass an updated version of the database for possible correlations between ethnicity and brain tumour risk.

Underlying genetic variation in populations from different geographic regions – where certain mutations are more or less common – could be a factor, Khanolkar acknowledged.

One expert, commenting on the study, pointed to other possible culprits.

“Two additional factors which might be of interest in this context are height and, in women, hormone replacement therapy,” said James Green, a clinical epidemiologist at the University of Oxford.

“Risk of brain tumours – as of most cancers – is higher in taller people, and taller people tend to be richer and more educated,” he noted.

“Hormone replacement therapy increases risk of brain tumours, and its use tends to vary by socio-economic group.”

© – AFP, 2016

Read: Four proposals to bring in tighter gun controls in the US are rejected

Read: SUV that rolled and killed Anton Yelchin was being recalled

Author
View 23 comments
Close
23 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds